We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




mage: Combining genetic factors with markers of biological ageing could enable a simple blood test to identify dementia risk before symptoms emerge (photo courtesy of Shutterstock)

Blood-Based “Ageing Clock” Helps Predict Dementia Risk and Earlier Onset

A new blood test using a metabolomic ageing clock plus genetic data stratifies dementia risk and signals earlier onset. More...
14 May 2026
Image: Processed on IDS’ random-access automation platforms, the comprehensive portfolio enables direct ChLIA measurement of total testosterone, SHBG, and free testosterone (photo courtesy of Revvity)

FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing

Revvity receives FDA clearance for total testosterone assay enabling comprehensive automated testing. More...
13 May 2026
Image: Pleiotropic synapse-related genes expressed in peripheral leukocytes of patients with major depressive disorder. The figure summarizes molecular pathways shared between peripheral immune alterations and central synaptic processes in major depressive disorder (Adri, A.S., Nóbile, A.L., de Albuquerque, D.G. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-39284-y)

Gene Signature Shows Promise for Depression Biomarker Testing

Researchers identify an 18-gene blood signature that distinguishes major depression and highlights neuroimmune comorbidity links. More...
13 May 2026
Image: IsoPSA is a blood-based test designed to aid in prostate biopsy decision‑making for men aged 50 years and older with elevated PSA levels (image credit: Shutterstock)

Blood Test Refines Biopsy Decisions in Prostate Cancer

A blood-based test gains ISO 13485 certification, enabling scaled use to refine prostate biopsy decisions. More...
13 May 2026
Image: The platform is built on a foundation model of tumor and immune biology, integrating genomic, transcriptomic, immune, and clinical signals to generate biologically grounded insights (image credit: 123RF)

AI-Driven Tumor Profiling Initiative Targets Precision Therapy Development

An AI platform integrates DNA/RNA and immune profiling to guide treatment selection across more than 20 cancer types. More...
13 May 2026
Image: Schematic overview of the GlycoHBF workflow, from collection of 15 body fluid types to standardized processing and dual-layer proteomic and glycoproteomic profiling (Yong Zhang, CC BY-NC-ND)

Researchers Map Protein and Glycosylation Across 15 Human Body Fluids

A standardized glycoproteomic atlas of 15 body fluids enables cross-fluid comparisons and improves liquid biopsy specificity. More...
13 May 2026
Image: The addition of pTau 217 complements blood-based approaches for clinical decision-making in neurology workflows. The fully automated format supports scalability on the LUMIPULSE G platform (photo courtesty of Shutterstock)

CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics

Fujirebio announced CE marking for the Lumipulse G pTau 217 Plasma assay, a fully automated test that quantitatively measures pTau 217 in human plasma. More...
13 May 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
HPV Molecular Test
BD Onclarity HPV Assay
Copyright © 2000-2026 Globetech Media. All rights reserved.